The Manitowoc Company, Inc.
MTWThe Manitowoc Company, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +109.2% in a year while annual EPS moved −87.2% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is between stages. Underneath, the last four quarters read mixed, and 118% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
The Manitowoc Company, Inc. trades at $20.9, between stages. That is +49.1% against its own 200-day average. It sits at 95% of a 52-week range of $10 to $21. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is between stages. At $20.9 it trades +49.1% versus its 200-day average and sits at 95% of its 52-week range ($10–$21).
Against the market, two honest reads. Cumulative: over the last 1.2 years the stock moved +60% while the S&P 500 moved +21% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
The Manitowoc Company, Inc. trades at 37.9× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 37.9× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −87.2% against a +109.2% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
The Manitowoc Company, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +2.8% | +3.3% | — | — |
| Profit | −83.3% | — | — | — |
| EPS | −87.2% | — | — | — |
| Stock price | +109.2% | — | — | — |
4-Factor Sector Score
56.3/100 — rank 4 of 21 in Farm & Heavy Construction Machinery · 55% evidence confidence
The Manitowoc Company, Inc. scores 56.3 out of 100 against the 21 companies it is compared with in Farm & Heavy Construction Machinery, ranking 4. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 17.5 + 7.8 + 14 + 17 = 56.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
The Manitowoc Company, Inc. reported $0.5 B of revenue in the Mar 26 quarter, +4.3% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 6.8% a year. The last full year, FY25, came in at $2.2 B. The last four reported quarters add to $2.3 B.
FY25 revenue came in at $2.2 B (+2.8% on the year), capping 4 years at 6.8% compound. The latest quarter (Mar 26) printed $0.5 B, +4.3% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +5.0% growth against the decade's 6.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +5.1% over the last 4 quarters against +0.9%/yr over the last 8 — accelerating; TTM profit −75.0% vs −29.3%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
The Manitowoc Company, Inc.'s operating margin is 0.0% in the Mar 26 quarter, −2.1 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −4.4% to 4.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.0%, −2.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −4.4%–4.0%.
🚨 Why the margin moved: operating margin went −2.1 pp year on year while gross margin went +1.3 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
The Manitowoc Company, Inc. posted a net loss of $0.01 B in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The 4-year compound rate is 0.0%. That loss is 2.0% of the quarter's revenue. The same quarter a year earlier lost $0.01 B. 4 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.0 B, null year on year. On the full year, FY25 printed $0.0 B (−83.3%), and the 4-year compound rate is 0.0%.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 118% of The Manitowoc Company, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.0 B of operating cash against $0.0 B of profit. After $0.0 B of capital spending, $−0.0 B was left as free cash.
FY25: operating cash of $0.0 B against reported profit of $0.0 B, leaving free cash of $−0.0 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 118% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
The Manitowoc Company, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
The Manitowoc Company, Inc. earns a ROE of 1% in FY25. That is up from a trough of −22% in FY22. Return on invested capital clears the cost of that capital by −5.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 0.4% net margin on 1.23× asset turns.
FY25 ROE is 1%, recovered from a FY22 trough of −22% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): 0.4% net margin × 1.23× asset turns × 2.60× balance-sheet leverage ≈ 1.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 4.4% − 10.1% = a −5.7 pp spread. The 10.1% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend
The Manitowoc Company, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
The Manitowoc Company, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
The Manitowoc Company, Inc. carries total debt of $0.5 B against shareholder equity of $0.7 B as of Mar 26, a debt-to-equity of 0.72. On the annual view that ratio went from 0.67 in FY21 to 0.73 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $0.5 B against shareholder equity of $0.7 B — a debt-to-equity of 0.72. On the annual view, debt-to-equity went from 0.67 (FY21) to 0.73 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
3.5% of The Manitowoc Company, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 3.5% of the float is sold short, and at typical trading volumes it would take about 2.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
The Manitowoc Company, Inc.: the Z-score reads 2.11. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.11 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.11.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Deere & CompanyDE | 66.4/100Favorable setup85% evidence | BREAKING OUT | 19.8/35 Revenue 8.3% · PAT -6.4% · OPM change -1.7 pp 95% evidence | 15.9/25 ROCE 9.1% · OPM 13.4% 76% evidence | 12.5/20 P/E 32.8× · PEG 1 65% evidence | 18.2/20 RS sector 13.8% · RS bench 13.1% · 1Y 42.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 15.9 + 12.5 + 18.2 = 66.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Caterpillar Inc.CAT | 63.6/100Mixed-positive evidence81% evidence | ASLEEP | 27.5/35 Revenue 18.4% · PAT 14.9% · OPM change 4.5 pp 83% evidence | 21.2/25 ROCE 22.2% · OPM 22.2% 76% evidence | 5.4/20 P/E 45.2× · PEG 2.48 65% evidence | 9.5/20 RS sector 0.8% · RS bench 0.5% · 1Y 67.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 21.2 + 5.4 + 9.5 = 63.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 3CNH Industrial N.V.CNH | 58.9/100Mixed-positive evidence66% evidence | BREAKING OUT | 14.4/35 Revenue -4% · PAT -62.5% · OPM change -3.8 pp 53% evidence | 10.8/25 ROCE 1% · OPM 9.9% 57% evidence | 14.2/20 P/E 35.5× · PEG 0.46 65% evidence | 19.5/20 RS sector 17.7% · RS bench 16.8% · 1Y 23.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 10.8 + 14.2 + 19.5 = 58.9 · Decision use: Price leads the evidence: RS versus the benchmark is 16.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4The Manitowoc Company, Inc.this pageMTW | 56.3/100Thin evidence · provisional55% evidence | BREAKING OUT | 17.5/35 Revenue 5.2% · PAT -82.6% · OPM change -0.5 pp 40% evidence | 7.8/25 ROCE 0.2% · OPM 0.6% 57% evidence | 14.0/20 P/E 58.3× · PEG 0.14 65% evidence | 17.0/20 RS sector 46.3% · RS bench 45.2% · 1Y 109.2%7 of 12 weeks ahead 70% evidence |
| Exact sum: 17.5 + 7.8 + 14 + 17 = 56.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Blue Bird CorporationBLBD | 54.9/100Mixed-positive evidence66% evidence | ASLEEP | 19.3/35 Revenue 10.1% · PAT 21.1% · OPM change 1.7 pp 53% evidence | 13.6/25 ROCE 10.4% · OPM 11.1% 57% evidence | 15.3/20 P/E 13.5× · PEG 0.52 65% evidence | 6.7/20 RS sector -3.8% · RS bench -4.1% · 1Y 3.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 13.6 + 15.3 + 6.7 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Federal Signal CorporationFSS | 53.2/100Thin evidence · provisional56% evidence | ASLEEP | 21.3/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence | 15.6/25 ROCE 6.3% · OPM 15.9% 76% evidence | 9.9/20 P/E 27.7× · PEG — 15% evidence | 6.4/20 RS sector -6.1% · RS bench -6.6% · 1Y -7.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 15.6 + 9.9 + 6.4 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7AGCO CorporationAGCO | 52.9/100Thin evidence · provisional56% evidence | TURNING | 19.6/35 Revenue — · PAT — · OPM change 1 pp 39% evidence | 9.7/25 ROCE 1.7% · OPM 3.4% 76% evidence | 11.0/20 P/E 16.6× · PEG — 15% evidence | 12.6/20 RS sector -1% · RS bench -1.7% · 1Y 9.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 9.7 + 11 + 12.6 = 52.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Gencor Industries, Inc.GENC | 51.5/100Thin evidence · provisional60% evidence | BREAKING OUT | 13.3/35 Revenue -10.3% · PAT -7.1% · OPM change -4.5 pp 53% evidence | 11.5/25 ROCE 2% · OPM 12.5% 57% evidence | 11.6/20 P/E 17× · PEG 1.32 65% evidence | 15.1/20 RS sector 8.7% · RS bench 8.1% · 1Y 13%6 of 12 weeks ahead 70% evidence |
| Exact sum: 13.3 + 11.5 + 11.6 + 15.1 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Oshkosh CorporationOSK | 48.7/100Thin evidence · provisional56% evidence | FADING | 16.2/35 Revenue — · PAT — · OPM change -4.1 pp 39% evidence | 13.2/25 ROCE 3.4% · OPM 3.5% 76% evidence | 10.6/20 P/E 17.6× · PEG — 15% evidence | 8.7/20 RS sector -4.2% · RS bench -5% · 1Y 8.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 13.2 + 10.6 + 8.7 = 48.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Alamo Group Inc.ALG | 48.2/100Mixed-negative evidence66% evidence | FADING | 16.6/35 Revenue 2.3% · PAT -12.2% · OPM change -1.3 pp 53% evidence | 13.3/25 ROCE 3% · OPM 10.1% 57% evidence | 10.8/20 P/E 19.7× · PEG 1.36 65% evidence | 7.5/20 RS sector -8.5% · RS bench -9.2% · 1Y -15.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 13.3 + 10.8 + 7.5 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11PACCAR IncPCAR | 45.6/100Mixed-negative evidence81% evidence | FADING | 16.2/35 Revenue -10.6% · PAT -18.5% · OPM change 0.5 pp 83% evidence | 13.2/25 ROCE 2.7% · OPM 11.7% 76% evidence | 9.6/20 P/E 25.2× · PEG 1.48 65% evidence | 6.6/20 RS sector -4.2% · RS bench -4.8% · 1Y 18.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 13.2 + 9.6 + 6.6 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Astec Industries, Inc.ASTE | 41.1/100Thin evidence · provisional60% evidence | ASLEEP | 18.1/35 Revenue 11.5% · PAT 73.3% · OPM change -3.9 pp 53% evidence | 8.1/25 ROCE 1% · OPM 2.3% 57% evidence | 11.4/20 P/E 48.1× · PEG 1.01 65% evidence | 3.5/20 RS sector -23.7% · RS bench -24.2% · 1Y -14.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.1 + 8.1 + 11.4 + 3.5 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Terex CorporationTEX | 40.5/100Thin evidence · provisional56% evidence | ASLEEP | 15.6/35 Revenue — · PAT — · OPM change -10.3 pp 39% evidence | 10.8/25 ROCE 2.8% · OPM -4.7% 76% evidence | 9.4/20 P/E 36.9× · PEG — 15% evidence | 4.7/20 RS sector -6.4% · RS bench -7.1% · 1Y 13.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 10.8 + 9.4 + 4.7 = 40.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Lindsay CorporationLNN | 39.5/100Mixed-negative evidence75% evidence | ASLEEP | 12.5/35 Revenue -7.1% · PAT -27.3% · OPM change -2.5 pp 83% evidence | 13.0/25 ROCE 2.7% · OPM 11.5% 76% evidence | 7.7/20 P/E 21× · PEG 2.04 65% evidence | 6.3/20 RS sector -6.7% · RS bench -7.3% · 1Y -14.9%1 of 12 weeks ahead 70% evidence |
| Exact sum: 12.5 + 13 + 7.7 + 6.3 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15SunScout Holding LimitedSNSC | 55.7/100Thin evidence · provisional11% evidence | 17.5/35 Revenue — · PAT — · OPM change — 0% evidence | 18.2/25 ROCE 30.5% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 17.5 + 18.2 + 10 + 10 = 55.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Wabash National CorporationWNC | 44.0/100Thin evidence · provisional50% evidence | FADING | 12.1/35 Revenue — · PAT — · OPM change -99.9 pp 39% evidence | 5.0/25 ROCE -2.7% · OPM -17.3% 76% evidence | 11.3/20 P/E 1.7× · PEG — 15% evidence | 15.6/20 RS sector 11.6% · RS bench 10.5% · 1Y 8.7%11 of 12 weeks ahead 70% evidence |
| Exact sum: 12.1 + 5 + 11.3 + 15.6 = 44 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Aebi Schmidt Holding AGAEBI | 38.9/100Thin evidence · provisional50% evidence | ASLEEP | 15.6/35 Revenue 61.2% · PAT -60.9% · OPM change -2.4 pp 53% evidence | 10.1/25 ROCE 1.3% · OPM 3.4% 57% evidence | 8.8/20 P/E 80.9× · PEG — 15% evidence | 4.4/20 RS sector -9.5% · RS bench -10.2% · 1Y -4.1%5 of 12 weeks ahead 70% evidence |
| Exact sum: 15.6 + 10.1 + 8.8 + 4.4 = 38.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Titan International, Inc.TWI | 38.4/100Thin evidence · provisional50% evidence | ASLEEP | 16.7/35 Revenue — · PAT — · OPM change -5.1 pp 39% evidence | 6.8/25 ROCE 1.1% · OPM -2.7% 76% evidence | 10.9/20 P/E 16.8× · PEG — 15% evidence | 4.0/20 RS sector -16.4% · RS bench -17.2% · 1Y -13.1%1 of 12 weeks ahead 70% evidence |
| Exact sum: 16.7 + 6.8 + 10.9 + 4 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Columbus McKinnon CorporationCMCO | 34.5/100Thin evidence · provisional50% evidence | BREAKING OUT | 14.1/35 Revenue — · PAT — · OPM change -37 pp 39% evidence | 6.0/25 ROCE -0.6% · OPM -35% 76% evidence | 8.7/20 P/E 82.1× · PEG — 15% evidence | 5.7/20 RS sector -8.3% · RS bench -9.1% · 1Y 7%8 of 12 weeks ahead 70% evidence |
| Exact sum: 14.1 + 6 + 8.7 + 5.7 = 34.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Hyster-Yale, Inc.HY | 29.3/100Thin evidence · provisional50% evidence | ASLEEP | 8.9/35 Revenue -12.2% · PAT -175.7% · OPM change -5.8 pp 53% evidence | 6.3/25 ROCE -2.8% · OPM -3.5% 57% evidence | 8.5/20 P/E 263.3× · PEG — 15% evidence | 5.6/20 RS sector -8.5% · RS bench -9% · 1Y -8.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 8.9 + 6.3 + 8.5 + 5.6 = 29.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21CEA Industries Inc.BNC | 28.2/100Thin evidence · provisional50% evidence | 10.7/35 Revenue — · PAT — · OPM change -2254.1 pp 39% evidence | 3.0/25 ROCE -43.5% · OPM -992.9% 76% evidence | 11.5/20 P/E 1.2× · PEG — 15% evidence | 3.0/20 RS sector -63.7% · RS bench -65.3% · 1Y -85.3%0 of 6 weeks ahead to 2026-08-07 70% evidence | |
| Exact sum: 10.7 + 3 + 11.5 + 3 = 28.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is The Manitowoc Company, Inc.'s stock price today?
The Manitowoc Company, Inc. trades at $20.9, +109.2% over the past year. The company is valued at $1.0 B. The stock sits at 95% of its 52-week range of $10–$21, +49.1% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. — as of 17 September 2026.
What were The Manitowoc Company, Inc.'s latest quarterly results?
The Manitowoc Company, Inc. reported revenue of $0.5 B and a net loss of $0.0 B for the Mar 26 quarter. Earnings per share were $−0.17. The operating margin was 0.0%, 2.1 pp lower than a year earlier. — as of 17 September 2026.
What is The Manitowoc Company, Inc.'s revenue?
The Manitowoc Company, Inc. reported revenue of $0.5 B in the Mar 26 quarter, +4.3% year on year. For the full FY25 fiscal year, revenue was $2.2 B (+2.8%). Over the last 4 years revenue compounded at 6.8% a year. — as of 17 September 2026.
What is The Manitowoc Company, Inc.'s profit?
The Manitowoc Company, Inc. earned $−0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 17 September 2026.
What is The Manitowoc Company, Inc.'s market cap?
The Manitowoc Company, Inc.'s market capitalisation is $1.0 B at a stock price of $20.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
Does The Manitowoc Company, Inc. pay a dividend?
No — The Manitowoc Company, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 17 September 2026.
How is The Manitowoc Company, Inc. performing?
The Manitowoc Company, Inc.'s latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
Is The Manitowoc Company, Inc. beating the market?
On recent form, yes — The Manitowoc Company, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.2 years the stock moved +60% against the S&P 500's +21% — ahead of the index over the full window. — as of 17 September 2026.
Will The Manitowoc Company, Inc.'s stock price go up?
This page publishes no price forecast for The Manitowoc Company, Inc. What it measures instead: the stock price is $20.9. Direction is not something this site claims to know. — as of 17 September 2026.
Is the market betting against The Manitowoc Company, Inc.?
Somewhat — short interest is 3.5% of The Manitowoc Company, Inc.'s tradable float, about 2.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
Does The Manitowoc Company, Inc. have too much debt?
It is moderate — The Manitowoc Company, Inc.'s debt-to-equity is 0.77. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 17 September 2026.
What is The Manitowoc Company, Inc.'s capex?
The Manitowoc Company, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 17 September 2026.
What is The Manitowoc Company, Inc.'s cash flow?
The Manitowoc Company, Inc. generated $0.0 B of operating cash flow in FY25 and $−0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 17 September 2026.
Is The Manitowoc Company, Inc.'s profit real cash?
Yes — over the last 3 fiscal years, 118% of The Manitowoc Company, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.0 B against reported profit of $0.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 17 September 2026.
How financially safe is The Manitowoc Company, Inc.?
On the balance sheet, the Z-score reads 2.11 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 17 September 2026.
Where is The Manitowoc Company, Inc. in its business cycle?
The Manitowoc Company, Inc.'s FY25 operating margin was 2.2%, against a 5-year band of −4.4%–4.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the The Manitowoc Company, Inc. story?
The sharpest disagreement: the price moved +109.2% in a year while annual EPS moved −87.2% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is The Manitowoc Company, Inc. a stock worth studying right now?
This is not investment advice. The machine read: The Manitowoc Company, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!